WO2008038119A3 - Composition contenant un complexe de coenzyme q10 et de cyclodextrines et son utilisation pour le traitement de pathologies du système nerveux central - Google Patents

Composition contenant un complexe de coenzyme q10 et de cyclodextrines et son utilisation pour le traitement de pathologies du système nerveux central Download PDF

Info

Publication number
WO2008038119A3
WO2008038119A3 PCT/IB2007/002820 IB2007002820W WO2008038119A3 WO 2008038119 A3 WO2008038119 A3 WO 2008038119A3 IB 2007002820 W IB2007002820 W IB 2007002820W WO 2008038119 A3 WO2008038119 A3 WO 2008038119A3
Authority
WO
WIPO (PCT)
Prior art keywords
carotene
cyclodextrin
complex
treatment
composition
Prior art date
Application number
PCT/IB2007/002820
Other languages
English (en)
Other versions
WO2008038119A2 (fr
Inventor
Rosario Ammirante
Felice Piero Molinari
Monte Federico Mauro Del
Original Assignee
Rosario Ammirante
Felice Piero Molinari
Monte Federico Mauro Del
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rosario Ammirante, Felice Piero Molinari, Monte Federico Mauro Del filed Critical Rosario Ammirante
Publication of WO2008038119A2 publication Critical patent/WO2008038119A2/fr
Publication of WO2008038119A3 publication Critical patent/WO2008038119A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/385—Concentrates of non-alcoholic beverages
    • A23L2/39—Dry compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/10—General methods of cooking foods, e.g. by roasting or frying
    • A23L5/15—General methods of cooking foods, e.g. by roasting or frying using wave energy, irradiation, electrical means or magnetic fields, e.g. oven cooking or roasting using radiant dry heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne une composition contenant : (a) un complexe de coenzyme Q10 et au moins une cyclodextrine; et (b) au moins un carotène. L'invention concerne également l'utilisation de ladite composition pour le traitement de diverses maladies, en particulier de maladies neurodégénératives du système nerveux central, spécialement la maladie de Parkinson (PD).
PCT/IB2007/002820 2006-09-29 2007-09-26 Composition contenant un complexe de coenzyme q10 et de cyclodextrines et son utilisation pour le traitement de pathologies du système nerveux central WO2008038119A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2006A001874 2006-09-29
IT001874A ITMI20061874A1 (it) 2006-09-29 2006-09-29 Composizione per il trattamento degli stati patologici neurodegenerativi del sistema nervoso centrale ed in particolare nel morbo di parkinson

Publications (2)

Publication Number Publication Date
WO2008038119A2 WO2008038119A2 (fr) 2008-04-03
WO2008038119A3 true WO2008038119A3 (fr) 2008-11-06

Family

ID=39190249

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/002820 WO2008038119A2 (fr) 2006-09-29 2007-09-26 Composition contenant un complexe de coenzyme q10 et de cyclodextrines et son utilisation pour le traitement de pathologies du système nerveux central

Country Status (2)

Country Link
IT (1) ITMI20061874A1 (fr)
WO (1) WO2008038119A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU100797B1 (en) * 2018-05-15 2019-11-15 Univ Luxembourg 2-hydroxypropyl-beta-cyclodextrin for use in a method of treatment of a parkinsonian condition
FR3117339A1 (fr) 2020-12-16 2022-06-17 Naos Institute Of Life Science Utilisation des bactériorubérines et leurs dérivés glycosylés pour prévenir et traiter les maladies impliquant une dérégulation de l’agrégation des protéines, comme les maladies neurodégénératives

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004011423A2 (fr) * 2002-07-29 2004-02-05 Hawaii Biotech, Inc. Analogues de carotenoides structuraux pour l'inhibition et la reduction de maladie
CN1634075A (zh) * 2004-10-28 2005-07-06 昆明翔昊科技有限公司 含番茄红素和辅酶q10的制剂及其制备方法
US7030102B1 (en) * 2003-05-06 2006-04-18 Bioactives, Llc Highly bioavailable coenzyme Q-10 cyclodextrin complex
EP1681053A1 (fr) * 2003-10-31 2006-07-19 Kaneka Corporation Composition contenant une coenzyme q reduite

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004011423A2 (fr) * 2002-07-29 2004-02-05 Hawaii Biotech, Inc. Analogues de carotenoides structuraux pour l'inhibition et la reduction de maladie
US7030102B1 (en) * 2003-05-06 2006-04-18 Bioactives, Llc Highly bioavailable coenzyme Q-10 cyclodextrin complex
EP1681053A1 (fr) * 2003-10-31 2006-07-19 Kaneka Corporation Composition contenant une coenzyme q reduite
CN1634075A (zh) * 2004-10-28 2005-07-06 昆明翔昊科技有限公司 含番茄红素和辅酶q10的制剂及其制备方法

Also Published As

Publication number Publication date
WO2008038119A2 (fr) 2008-04-03
ITMI20061874A1 (it) 2006-12-29

Similar Documents

Publication Publication Date Title
WO2009071690A3 (fr) Dérivés d'oxindole à double substitution en positions 5 et 6 et leur utilisation pour traiter des maladies liées à la vasopressine
WO2007092329A3 (fr) Compositions pharmaceutiques comprenant du dextrométhorphane et de la quinidine pour le traitement de la dépression, de l'anxiété et des troubles neurodégénératifs
WO2007127505A3 (fr) Composés chimiques
EP1940373B8 (fr) 1-fluoro-1-deoxy-scyllo-inositol destine au traitement de la maladie d'alzheimer
WO2009052439A3 (fr) Régimes immunothérapeutiques dépendant du statut de l'apoe
GB2463833A (en) Methods and compositions for the treatment of neurological disorders
WO2006095029A3 (fr) Conjugues di-polymere-proteine et procedes de preparation de ceux-ci
IL192636A0 (en) Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine useful for the treatment of alzheimer's disease via gaba receptors
HK1103393A1 (en) Cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes
IL184371A (en) Use of an anti il-31ra antibody in the manufacture of a medicament for treating skin disorders
WO2008021210A3 (fr) Méthodes et compositions pour le traitement de troubles neurodégénératifs
IL177787A0 (en) 1-aminovyclohexane derivatives for the treatment of agitation and other behavioral disorders, especially those associated with alzheimer's disease
EP1923388A4 (fr) Agent protegeant des cellules du cerveau/neuronales et agent therapeutique pour des troubles du sommeil
WO2009071689A3 (fr) Dérivés d'oxindole substitués par halogène en position 5 et leur utilisation pour traiter des maladies liées à la vasopressine
WO2008060362A3 (fr) Procédés et compositions pour le traitement de maladies et de troubles de la peau
WO2010058926A3 (fr) Composition pharmaceutique contenant un extrait de gingembre ou du shogaol
WO2007022305A3 (fr) 2-aminoimidazopyridines destinees a traiter des maladies neurodegeneratives
WO2007133983A3 (fr) 2-aminobenzimidazoles utilisés pour traiter des maladies neurodégénératives
WO2010041252A3 (fr) Utilisation d'un extrait d'écorce de cannelle dans le traitement de maladies associées à l'amyloïde
WO2009062750A3 (fr) Isoformes solubles actives de neuréguline modifiées de façon post-traductionnelle
WO2004082584A3 (fr) Utilisation d'antagonistes du recepteur 5-ht2c pour traiter la schizophrenie
USD554735S1 (en) Ultra-violet liquids disinfection device
WO2007144699A3 (fr) Procédé pour la préparation d'alfuzosine
WO2008038119A3 (fr) Composition contenant un complexe de coenzyme q10 et de cyclodextrines et son utilisation pour le traitement de pathologies du système nerveux central
PL1801126T3 (pl) Uwodorniony kauczuk nitrylowy o wąskim rozkładzie masy cząsteczkowej, sposób jego wytwarzania i jego zastosowanie

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07825195

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 07825195

Country of ref document: EP

Kind code of ref document: A2